Volume 83, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Because some febrile patients are unable to swallow or retain oral antipyretic drugs, we carried out a double-blind, placebo-controlled trial in which intravenous ibuprofen (IV-ibuprofen) was given to adults hospitalized with fever associated with acute uncomplicated falciparum malaria treated with oral artesunate plus mefloquine. Thirty patients received IV-ibuprofen 400 mg and 30 received placebo every 6 hours for 72 hours. Reduction in the area above 37.0°C versus time curve was significantly greater for IV-ibuprofen than for placebo during the first 72 hours after first administration. No patients developed severe malaria; parasite clearance was delayed in the patients whose fevers were controlled by IV-ibuprofen (median 37.3 hours versus 23.7 hours in the placebo group [ = 0.0024]). This difference did not appear to be clinically important Adverse events, none considered severe, occurred equally in both groups. IV-ibuprofen was effective and well tolerated in reducing fever in febrile inpatients with malaria.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Looareesuwan S, , 1992. Overview: pathophysiology and management of cerebral malaria. Southeast Asian J Trop Med Public Health 23 (Suppl 4): 155165. [Google Scholar]
  2. Patel CC, , 1971. Acute febrile encephalopathy in Ugandan children. Afr J Med Sci 2: 127134. [Google Scholar]
  3. Young GB, , 2009. Coma. Ann NY Acad Sci 1157: 3247.[Crossref] [Google Scholar]
  4. Looareesuwan S, Phillips RE, White NJ, Kietinun S, Karbwang J, Rackow C, Turner RC, Warrell DA, , 1985. Quinine and severe falciparum malaria in late pregnancy. Lancet 2: 48.[Crossref] [Google Scholar]
  5. Warrell DA, Molyneux ME, Beales PF, , 1990. Severe and complicated malaria. Trans Roy Soc Trop Med Hyg 84 (Suppl 2): 165. [Google Scholar]
  6. Hemmer CJ, Kern P, Holst FG, Nawroth PP, Dietrich M, , 1991. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am J Trop Med Hyg 45: 608612. [Google Scholar]
  7. Schönhöfer P, Offerhaus L, Herxheimer A, , 2003. Dipyrone and agranulocytosis: what is the risk? Lancet Mar 361: 968969.[Crossref] [Google Scholar]
  8. Schwartz JI, Chan CC, Mukhopadhyay S, McBride KJ, Jones TM, Adcock S, Moritz C, Hedges J, Grasing K, Dobratz D, Cohen RA, Davidson MH, Bachmann KA, Gertz BJ, , 1999. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 65: 653660.[Crossref] [Google Scholar]
  9. Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB, , 1997. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336: 912918.[Crossref] [Google Scholar]
  10. Jegerschöld C, Pawelzik SC, Purhonen P, Bhakat P, Gheorghe KR, Gyobu N, Mitsuoka K, Morgenstern R, Jakobsson PJ, Herbert H, , 2008. Structural basis for induced formation of the inflammatory mediator prostaglandin E2 . Proc Natl Acad Sci USA 105: 1111011115.[Crossref] [Google Scholar]
  11. Bone RC, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD, Ursprung JJ, , 1989. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndromes. Prostaglandin E1 Study Group. Chest 96: 114119.[Crossref] [Google Scholar]
  12. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB, , 1991. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19: 13391347.[Crossref] [Google Scholar]
  13. World Health Organization, Communicable Diseases Cluster, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1S90. [Google Scholar]
  14. Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilaiaratana P, Thimasarn K, Looareesuwan S, , 2005. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 36: 591596. [Google Scholar]
  15. Tangpukdee N, Krudsood S, Thanachartwet W, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Wilairatana P, Phongtananant S, Kano S, Looareesuwan S, , 2005. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 36: 10851091. [Google Scholar]
  16. Krudsood S, Tangpukdee N, Thanchatwet V, Wilairatana P, Srivilairit S, Pothipak N, Jianping S, Guoqiao L, Brittenham GM, Looareesuwan S, , 2007. Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 38: 971978. [Google Scholar]
  17. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. World Health Organ Tech Rep Ser 529: 3036. [Google Scholar]
  18. Krishna S, Pukrittayakamee S, Supanaranond W, ter Kuile F, Supputamangkol Y, Attatamsoonthorn K, Ruprah M, White NJ, , 1995. Fever in uncomplicated Plasmodium falciparum malaria: randomized double-‘blind’ comparison of ibuprofen and paracetamol treatment. Trans R Soc Trop Med Hyg 89: 507509.[Crossref] [Google Scholar]
  19. Matsiégui PB, Missinou MA, Necek M, Mavoungou E, Issifou S, Lell B, Kremsner PG, , 2008. Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial. Malar J 7: 91.[Crossref] [Google Scholar]
  20. Brandts CH, Ndjave M, Graninger W, Kremsner PG, , 1997. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704709.[Crossref] [Google Scholar]
  21. Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Björkman A, , 2006. Relationship between antipyretic effects and cytokine levels in uncomplicated falciparum malaria during different treatment regimes. Acta Trop 99: 7582.[Crossref] [Google Scholar]
  22. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM, . 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 9198. [Google Scholar]
  23. van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B, , 1996. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 10911097.[Crossref] [Google Scholar]
  24. Looareesuwan S, Sjostrom L, Krudsood S, Wilairatana P, Porter RS, Hills F, Warrell DA, , 1999. Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. Am J Trop Med Hyg 61: 2633. [Google Scholar]
  25. Kwiatkowski D, , 1989. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro . J Exp Med 169: 357361.[Crossref] [Google Scholar]
  26. Kwiatkowski D, , 1995 Malarial toxins and the regulation of parasite density. Parasitol Today 11: 206212.[Crossref] [Google Scholar]
  27. Kwiatkowski D, , 1993. TNF-inducing malaria toxin: a sheep in wolf's clothing? Ann Trop Med Parasitol 87: 613616.[Crossref] [Google Scholar]
  28. McGuire W, D'Alessandro U, Stephens S, Olaleye BO, Langerock P, Greenwood BM, Kwiatkowski D, , 1998. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans R Soc Trop Med Hyg 92: 5053.[Crossref] [Google Scholar]
  29. Matsiegui PB, Missinou MA, Issifou S, Necek M, Mavoungou E, , 2007. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria. Eur Cytokine Netw 18: 201205. [Google Scholar]
  30. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM, , 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 9198. [Google Scholar]
  31. Qiu HB, Pan JQ, Zhao YQ, Chen DC, , 1997. Effects of dexamethasone and ibuprofen on LPS-induced gene expression of TNF alpha, IL-1 beta, and MIP-1 alpha in rat lung. Zhongguo Yao Li Xue Bao 18: 165168. [Google Scholar]
  32. Cazanave S, Vadrot N, Tinel M, Berson A, Lettéron P, Larosche I, Descatoire V, Feldmann G, Robin MA, Pessayre D, , 2008. Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. Toxicol Appl Pharmacol 231: 336343.[Crossref] [Google Scholar]
  33. Udomsangpetch R, Pipitaporn B, Silamut K, Pinches R, Kyes S, Looareesuwan S, Newbold C, White NJ, , 2002. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA 99: 1182511829.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 14 Oct 2009
  • Accepted : 12 Mar 2010
  • Published online : 06 Jul 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error